Related Experiment Video
Updated: May 9, 2026
06:38
Detection of Abnormal Prion Protein by Immunohistochemistry
Published on: May 5, 2023
How structure shapes (dys)function: a perspective to understanding brain region-specific degeneration in prion
1German Center for Neurodegenerative Diseases (DZNE); Bonn, Germany.
Prion
|August 9, 2013
Summary
Neuronal structure influences nervous system function and dysfunction. Specific structural properties, like glial ensheathment and synaptic exposure, determine synapse vulnerability during neurodegeneration, explaining regional differences in neuronal loss.
Area of Science:
- Neuroscience
- Cell Biology
- Structural Biology
Background:
- Neuronal structure is intrinsically linked to nervous system function.
- The role of specific neuronal structural properties in selective vulnerability during neurodegeneration remains unclear.
- Understanding these properties is crucial for explaining regional differences in synaptic dysfunction.
Purpose of the Study:
- To investigate whether specific structural properties of neurons influence their selective removal during chronic neurodegeneration.
- To determine if structural characteristics underpin the differential susceptibility of synapses and neuronal compartments to degeneration in specific brain regions.
- To explore the relationship between neuronal structure and dysfunction.
Main Methods:
- Comparative ultrastructural analysis of the hippocampus and cerebellum.
- Examination of synaptic environments and glial ensheathment.
- Assessment of synaptic exposure to the extracellular environment.
Main Results:
- Early synaptic loss is not uniform across the brain during chronic neurodegeneration.
- Purkinje cell synapses remained intact, while pyramidal cell synapses degenerated.
- Differences in glial ensheathment and synaptic exposure in the hippocampus may explain regional susceptibility to degeneration.
Conclusions:
- Neuronal structure plays a critical role in determining synaptic vulnerability and selective loss during neurodegeneration.
- The degree of synaptic ensheathment by glial cells and synaptic exposure to the extracellular environment are key factors influencing neuronal dysfunction.
- Neuronal structure may predict not only function but also susceptibility to dysfunction.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...